---
schema_version: "secwatch.filing_event.v1"
accession: "0000899923-22-000006"
form_type: "8-K"
ticker: "MYGN"
cik: "0000899923"
company_name: "MYRIAD GENETICS INC"
filed_at: "2022-01-04T23:59:59+00:00"
generated_at: "2026-06-27T21:12:44.147272+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Myriad Genetics CSO Jerry Lanchbury to retire effective Jan 14, 2022

## Summary
- Dr. Jerry Lanchbury notified retirement as Chief Scientific Officer.
- Retirement effective January 14, 2022.
- Company expects to enter a separation and consulting agreement (terms to be filed later).
- No replacement has been announced.

## SEC filing metadata
- accession: 0000899923-22-000006
- form_type: 8-K
- ticker: MYGN
- cik: 0000899923
- company_name: MYRIAD GENETICS INC
- filed_at: 2022-01-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/899923/000089992322000006/0000899923-22-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/899923/000089992322000006/mygn-20220103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000899923-22-000006
- JSON: https://secwatch.observer/filing/0000899923-22-000006.json
- Plain text: https://secwatch.observer/filing/0000899923-22-000006.txt

## Key facts
- Executive change
  Jerry Lanchbury retired as Chief Scientific Officer at MYRIAD GENETICS INC.
  - Action: retired
  - Role: Chief Scientific Officer
  source text: On January 3, 2022, Jerry Lanchbury, Ph.D., notified Myriad Genetics, Inc. (the "Company") of his retirement as Chief Scientific Officer of the Company, effective January 14, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/899923/000089992322000006/0000899923-22-000006-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.